Islet Management, LP - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 132 filers reported holding CTI BIOPHARMA CORP in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
Islet Management, LP ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$2,100,000
-44.5%
500,000
-20.6%
1.02%
-60.0%
Q4 2022$3,786,300
+4.1%
630,000
+0.8%
2.55%
+166.0%
Q3 2022$3,638,000
-39.1%
625,000
-37.5%
0.96%
+58.2%
Q2 2022$5,970,000–1,000,000–0.61%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q3 2022.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders